Source: Annual Congress 2013 –Novel mechanisms in lung injury
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
K. Wakabayashi, M. Wilson, K. Tatham, K. O'Dea, M. Takata (London, United Kingdom). High-stretch, but not atelectasis, causes systemic cytokine release by lung-marginated monocytes. Eur Respir J 2013; 42: Suppl. 57, 653

Member's Comments

No comment yet.

Related content which might interest you: New IL-1 family IL-38 is highly expressed in alveolar cells of drug-induced lung injury and idiopathic pulmonary fibrosis Source: International Congress 2016 – ILD pathogenesis Year: 2016 A mouse model of acute lung injury implicates phospholipase Cε in neutrophilic inflammation through CXC chemokine production Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair Year: 2016 Microvesicles derived from alveolar macrophages mediate epithelial activation via a TNF dependant mechanism Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015 Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 640-646 Year: 2005 ATP selectively packages TNF within microvesicles released from alveolar macrophages Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair Year: 2016 Pirfenidone suppresses proinflammatory and antiangiogenetic cytokine production by alveolar macrophages (AMs) in idiopathic non specific interstitial pneumonia (iNSIP) Source: International Congress 2014 – ILDs 2 Year: 2014 The role of ATP and purinergic-receptor- signalling in the pathogenesis of ALI/ARDS Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 Dexamethasone inhibits secretory and cytosolic phospholipases A2 in alveolar macrophages in acute lung injury Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Heparin effect in alveolar cells and macrophages in an acute lung injury model Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015 Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs Source: Eur Respir J 2007; 29: 1105-1114 Year: 2007 TNF and IP-10 drive inflammation into hyperinflammation in the murine lung Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Effect of nintedanib on the release of angiogenic/angiostatic cytokines by alveolar macrophages (AMs) in interstitial lung diseases (ILD) Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Airway neutrophilia in COPD is not associated with increased neutrophil survival Source: Eur Respir J 2006; 28: 1163-1169 Year: 2006 Down-regulation of RIP140 can prevent LPS-induced inflammation and acute lung injury in mice via PPARγ Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury Year: 2015 Effects of ceramide pathway inhibition on the inflammatory response in lipopolysacharide-triggered lung injury Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications Year: 2015 Resolution of acute lung injury and inflammation: a translational mouse model Source: Eur Respir J 2012; 39: 1162-1170 Year: 2012 Inhibition of acute lung inflammation by removal of pulmonary intravascular macrophages (PIMs) Source: Eur Respir J 2001; 18: Suppl. 33, 79s Year: 2001 Neutrophilia is associated with the persistent parenchymal changes after acute lung injury Source: International Congress 2015 – Latest insights into chronic care Year: 2015 Impaired Alveolar Macrophage Efferocytosis in ARDS causes accumulation of apoptotic neutrophils & prolonged inflammation Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018 Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease Source: Eur Respir J 2006 Oct 01;28(4):824-831 Year: 2006